ABOS · Acumen Pharmaceuticals, Inc. · Executive Compensation

$2.97 -0.19 (-6.01%)

Russell 2000 member Rebalance outlook locked

Market Cap

$229.97M

72.32M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel O'Connell	Chief Executive Officer	$646,354	—	$412,482	$478,338	$305,725	$20,668	$1,863,567
Jim Doherty	President and Chief Development Officer	$520,000	—	$115,070	$133,419	$223,600	$20,770	$1,012,859
Matthew Zuga	Chief Financial Officer and Chief Business Officer	$486,993	—	$123,580	$143,429	$172,980	$21,807	$948,789

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel O'Connell	Chief Executive Officer	$621,494	—	$1,696,230	$2,036,867	$406,768	$19,328	$4,780,687
Jim Doherty	President and Chief Development Officer	$458,333	—	—	$1,493,004	$210,885	$19,859	$2,182,081
Matthew Zuga	Chief Financial Officer and Chief Business Officer	$468,263	—	$448,380	$537,977	$215,776	$19,118	$1,689,514

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel O'Connell	Chief Executive Officer	$597,590	—	$696,540	$2,190,177	$427,277	$18,427	$3,930,011
Matthew Zuga	Chief Financial Officer and Chief Business Officer	$450,253	—	$204,685	$699,003	$234,131	$18,217	$1,606,289
Derek Meisner	Chief Legal Officer	$455,663	$45,000	$163,748	$559,944	$236,945	$15,337	$1,476,637

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel O'Connell	Chief Executive Officer	$570,492	—	—	$1,760,850	$290,865	$39,845	$2,662,052
Derek Meisner	Chief Legal Officer	$141,705	$45,000	—	$1,039,500	$52,925	$538	$1,279,668
Matthew Zuga	Chief Financial Officer and Chief Business Officer	$429,836	—	—	$580,500	$163,148	$15,302	$1,188,786

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel O'Connell	President and Chief Executive Officer	$524,597	—	—	$676,217	$275,422	$1,600	$1,477,836
Matthew Zuga	Chief Financial Officer and Chief Business Officer	$315,430	$55,000	—	$257,280	$150,921	$200	$778,831
Eric Siemers	Chief Medical Officer	$336,159	—	—	$177,264	$124,283	$200	$637,906

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel O'Connell	President and Chief Executive Officer	$240,000	$96,000	—	—	—	—	$336,000
Eric Siemers	Chief Medical Officer	$180,000	$57,600	—	—	—	—	$237,600

Executive changes

Person	Role	Change	Effective	Filed
Dr. George Golumbeski	Chairman of the Board	Appointed	2025-11-06	2025-11-10
Dr. George Golumbeski	director	Appointed	2025-11-06	2025-11-10

Key facts CIK 1576885 CUSIP 00509G209 13F (30d) 70 filings 70 filers Visit website Investor relations